Eczema (Atopic Dermatitis)
Eczema (Atopic Dermatitis)
67484703ADM2001 Enrolling

Atopic Dermatitis – Research Trial (41 Weeks)

Treatment: Injection Age: 18 Years

Adults aged 18 years or older with a diagnosis of atopic dermatitis for 12 months or more and a weight of 50 to 180 kg are needed for this clinical research trial.  Eligible participants must have moderate to severe disease with plaques covering 10% or more of the body surface area (BSA).

Participants will receive investigational doses of treatment (active study drug) or placebo, via an injection form.  Study medication and study-related assessments will be provided at no cost.  Reimbursement for study-related expenses may be provided.

Study participation will last about 41 weeks and involve about 11 visits to the study center.

Participating Locations

Participating Experts

Dr. Maryam Shayesteh Alam


You May Also Be Interested In

Similar Trials

No Similar Trials Found

The following information is from

Last Update Posted: March 21, 2023



Terms and Conditions –
Purpose of Database. The U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine, has developed to provide patients, family members, and members of the public current information about clinical research studies.


Learn More About

Eczema (Atopic Dermatitis)

Learn More
2022 all rights reserved probity medical research inc
find a trial
filter trials
Skip to content